-
2
-
-
18144387938
-
Is idiopathic pulmonary fibrosis now treatable?
-
du Bois RM. Is idiopathic pulmonary fibrosis now treatable? Am J Respir Crit Care Med 2005; 171: 939-940.
-
(2005)
Am J Respir Crit Care Med
, vol.171
, pp. 939-940
-
-
du Bois, R.M.1
-
3
-
-
0034133548
-
Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS)
-
American Thoracic Society
-
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS) and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-664.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 646-664
-
-
-
4
-
-
0026758498
-
The clinical pharmacology of 6-mercaptopurine
-
Lennard L. The clinical pharmacology of 6-mercaptopurine. Eur J Clin Pharmacol 1992; 43: 329-339.
-
(1992)
Eur J Clin Pharmacol
, vol.43
, pp. 329-339
-
-
Lennard, L.1
-
5
-
-
0034034158
-
Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
-
McLeod HL, Krynetski EY, Relling MV, Evans WE. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 567-572.
-
(2000)
Leukemia
, vol.14
, pp. 567-572
-
-
McLeod, H.L.1
Krynetski, E.Y.2
Relling, M.V.3
Evans, W.E.4
-
6
-
-
0030934850
-
Molecular diagnosis of thiopurine S-methyltransferase deficiency: Genetic basis for azathioprine and mercaptopurine intolerance
-
Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 1997; 126: 608-614.
-
(1997)
Ann Intern Med
, vol.126
, pp. 608-614
-
-
Yates, C.R.1
Krynetski, E.Y.2
Loennechen, T.3
-
7
-
-
0036009619
-
The thiopurine S-methyltransferase gene locus - implications for clinical pharmacogenomics
-
McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus - implications for clinical pharmacogenomics. Pharmacogenomics 2002; 3: 89-98.
-
(2002)
Pharmacogenomics
, vol.3
, pp. 89-98
-
-
McLeod, H.L.1
Siva, C.2
-
8
-
-
3242762099
-
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants
-
Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 2004; 14: 407-417.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 407-417
-
-
Schaeffeler, E.1
Fischer, C.2
Brockmeier, D.3
-
9
-
-
0035871560
-
Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine and azathioprine
-
Evans WE, Hon YY, Bomgaars L, et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine and azathioprine. J Clin Oncol 2001; 19: 2293-2301.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2293-2301
-
-
Evans, W.E.1
Hon, Y.Y.2
Bomgaars, L.3
-
10
-
-
0037237923
-
Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD
-
Seidman EG. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Rev Gastroenterol Disord 2003; 3: Suppl. 1, S30-S38.
-
(2003)
Rev Gastroenterol Disord
, vol.3
, Issue.SUPPL. 1
-
-
Seidman, E.G.1
-
11
-
-
38849166399
-
Drug metabolite monitoring of azathioprine/6-MP therapy: Contribution of thiopurine methyltransferase gene polymorphisms: 69
-
Dervieux T, Matsutani M, Barry M, Siedman E. Drug metabolite monitoring of azathioprine/6-MP therapy: contribution of thiopurine methyltransferase gene polymorphisms: 69. Ther Drug Monit 2005; 27: 228.
-
(2005)
Ther Drug Monit
, vol.27
, pp. 228
-
-
Dervieux, T.1
Matsutani, M.2
Barry, M.3
Siedman, E.4
-
12
-
-
0032212759
-
Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine
-
Black AJ, McLeod HL, Capell HA, et al. Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Int Med 1998; 129: 716-718.
-
(1998)
Ann Int Med
, vol.129
, pp. 716-718
-
-
Black, A.J.1
McLeod, H.L.2
Capell, H.A.3
-
13
-
-
0034093057
-
Genotypic analysis of the thiopurine S-methyltransferase gene in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
-
Colombel JF, Ferrari N, Debuysere H, et al. Genotypic analysis of the thiopurine S-methyltransferase gene in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 2000; 118: 1025-1030.
-
(2000)
Gastroenterology
, vol.118
, pp. 1025-1030
-
-
Colombel, J.F.1
Ferrari, N.2
Debuysere, H.3
-
14
-
-
21744452321
-
Inosine triphosphate pyrophosphatease gene mutations predicts myelosuppresion in IBD patients treated with azathioprine
-
Zelinkova Z, Derijks LJ, Stokkers PC, et al. Inosine triphosphate pyrophosphatease gene mutations predicts myelosuppresion in IBD patients treated with azathioprine. Gastroenterology 2004; 126: Suppl. 2, A112.
-
(2004)
Gastroenterology
, vol.126
, Issue.SUPPL. 2
-
-
Zelinkova, Z.1
Derijks, L.J.2
Stokkers, P.C.3
-
15
-
-
12144285961
-
Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase)
-
Marinaki AM, Ansari A, Duley JA, et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004; 14: 181-187.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 181-187
-
-
Marinaki, A.M.1
Ansari, A.2
Duley, J.A.3
-
16
-
-
9944221077
-
The impact of thiopurine s-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation
-
Fabre MA, Jones DC, Bunce M, et al. The impact of thiopurine s-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation. Transpl Int 2004; 17: 531-539.
-
(2004)
Transpl Int
, vol.17
, pp. 531-539
-
-
Fabre, M.A.1
Jones, D.C.2
Bunce, M.3
-
17
-
-
11144340253
-
British Association of Dermatologists Therapy, Guidelines and Audit Subcommittee. Guidelines for prescribing azathioprine in dermatology
-
Anstey AV, Wakelin S, Reynolds NJ, British Association of Dermatologists Therapy, Guidelines and Audit Subcommittee. Guidelines for prescribing azathioprine in dermatology. Br J Dermatol 2004; 151: 1123-1132.
-
(2004)
Br J Dermatol
, vol.151
, pp. 1123-1132
-
-
Anstey, A.V.1
Wakelin, S.2
Reynolds, N.J.3
-
18
-
-
0038345082
-
Prospects and limits of pharmacogenetics: The thiopurine methyl transferase (TPMT) experience
-
Van Aken J, Schmedders M, Feurerstein G, Kollek R. Prospects and limits of pharmacogenetics: the thiopurine methyl transferase (TPMT) experience. Am J Pharmacogenomics 2003; 3: 149-155.
-
(2003)
Am J Pharmacogenomics
, vol.3
, pp. 149-155
-
-
Van Aken, J.1
Schmedders, M.2
Feurerstein, G.3
Kollek, R.4
-
19
-
-
0036667951
-
Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: Impact of thiopurine S-methyltransferase polymorphisms
-
Schwab M, Schaffeler E, Marx C, et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphisms. Pharmacogenetics 2002; 12: 421-423.
-
(2002)
Pharmacogenetics
, vol.12
, pp. 421-423
-
-
Schwab, M.1
Schaffeler, E.2
Marx, C.3
-
20
-
-
0036894866
-
Practical Pharmacogenetics: The cost effectiveness of screening for thiopurine S-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine
-
Marra CA, Esdaile JM, Anis AH. Practical Pharmacogenetics: The cost effectiveness of screening for thiopurine S-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. J Rheumatol 2002; 29: 2507-2512.
-
(2002)
J Rheumatol
, vol.29
, pp. 2507-2512
-
-
Marra, C.A.1
Esdaile, J.M.2
Anis, A.H.3
-
21
-
-
4644241129
-
Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease
-
Winter J, Walker A, Shapiro D, Gaffney D, Spooner RJ, Mills PR. Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20: 593-599.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 593-599
-
-
Winter, J.1
Walker, A.2
Shapiro, D.3
Gaffney, D.4
Spooner, R.J.5
Mills, P.R.6
-
22
-
-
33747167334
-
Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease
-
Priest VL, Begg EJ, Gardiner SJ, et al. Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease. Pharmacoeconomics 2006; 24: 767-781.
-
(2006)
Pharmacoeconomics
, vol.24
, pp. 767-781
-
-
Priest, V.L.1
Begg, E.J.2
Gardiner, S.J.3
-
23
-
-
33747168764
-
Cost-effectiveness of pharmacogenomics in clinical practice: A case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe
-
van den Akker-van Marle ME, Gurwitz D, Detmar SB, et al. Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe. Pharmacogenomics 2006; 7: 783-792.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 783-792
-
-
van den Akker-van Marle, M.E.1
Gurwitz, D.2
Detmar, S.B.3
-
24
-
-
0033941305
-
Screening for azathioprine toxicity: A pharmacoeconomic analysis based on a target case
-
Tavadia SM, Mydlarski PR, Reis MD, et al. Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case. J Am Acad Dermatol 2000; 42: 628-632.
-
(2000)
J Am Acad Dermatol
, vol.42
, pp. 628-632
-
-
Tavadia, S.M.1
Mydlarski, P.R.2
Reis, M.D.3
-
25
-
-
33745460088
-
Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study
-
Gisbert JP, Luna M, Mate J, Gonzalez-Guijarro L, Cara C, Pajares JM. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study. Hepatogastroenterology 2006; 53: 399-404.
-
(2006)
Hepatogastroenterology
, vol.53
, pp. 399-404
-
-
Gisbert, J.P.1
Luna, M.2
Mate, J.3
Gonzalez-Guijarro, L.4
Cara, C.5
Pajares, J.M.6
-
26
-
-
17644381606
-
Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: Effect on cost and adverse events
-
Sayani FA, Prosser C, Bailey RJ, Jacobs P, Fedorak RN. Thiopurine methyltransferase enzyme activity determination before treatment of inflammatory bowel disease with azathioprine: effect on cost and adverse events. Can J Gastroenterol 2005; 19: 147-151.
-
(2005)
Can J Gastroenterol
, vol.19
, pp. 147-151
-
-
Sayani, F.A.1
Prosser, C.2
Bailey, R.J.3
Jacobs, P.4
Fedorak, R.N.5
-
27
-
-
4344602852
-
Guidelines for the management of inflammatory bowel disease in adults
-
Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53: V1-V16.
-
(2004)
Gut
, vol.53
-
-
Carter, M.J.1
Lobo, A.J.2
Travis, S.P.L.3
-
28
-
-
3843109109
-
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee
-
Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004; 99: 1371-1385.
-
(2004)
Am J Gastroenterol
, vol.99
, pp. 1371-1385
-
-
Kornbluth, A.1
Sachar, D.B.2
-
29
-
-
4844231301
-
Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis
-
Luppi F, Cerri S, Beghe B, Fabbri LM, Richeldi L. Corticosteroid and immunomodulatory agents in idiopathic pulmonary fibrosis. Respir Med 2004; 98: 1035-1044.
-
(2004)
Respir Med
, vol.98
, pp. 1035-1044
-
-
Luppi, F.1
Cerri, S.2
Beghe, B.3
Fabbri, L.M.4
Richeldi, L.5
|